Motonobu Saito

22PUBLICATIONS
108CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpidemiological methodsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jan 10, 2026
Evaluation of NTRK Fusions Detection Method in Esophageal Squamous Cell Carcinoma and Gastric Adenocarcinoma.

Tomoyuki Momma, Motonobu Saito, Shotaro Nakajima

|Nov 27, 2025
KRAS G12A Identifies a High-Risk Subset in Resected Stage II-III Colorectal Cancer.

Tomoyuki Momma, Hirokazu Okayama, Sohei Hayashishita

|Sep 09, 2025
Extracellular vesicles of cancer cells induce FOXP3+ fibroblasts and facilitate tumor invasion via the Wnt3-β-catenin pathway.

Tomoaki Kimura, Kurara Takagane, Go Itoh

|Aug 18, 2025
GALNT7 Stratifies dMMR/MSI Colorectal Cancer into Distinct Molecular Subsets Associated with Prognosis and PD-L1 Expression.

Hiroya Suzuki, Hirokazu Okayama, Shotaro Nakajima

|Aug 13, 2025
Residual Tumor Resection After Anti-PD-1 Therapy: A Promising Treatment Strategy for Overcoming Immune Evasive Phenotype Induced by Anti-PD-1 Therapy in Gastric Cancer.

Hajime Matsuida, Kosaku Mimura, Shotaro Nakajima

|Feb 13, 2025
Lenvatinib suppress FGF19-FGFR4 signaling to enhance antitumor immune response in gastric cancer.

Yuya Maruyama, Motonobu Saito, Shotaro Nakajima

Pageof 4

Frequent Collaborators

12 joint publications

Kosaku Mimura

12 joint publications

Hirokazu Okayama

7 joint publications

Shotaro Nakajima

3 joint publications

Tomoyuki Momma